Evidence map›Paper›PMID 29968565›Full record

ArticleeLife2018

Dual leucine zipper kinase is required for mechanical allodynia and microgliosis after nerve injury.

Josette J Wlaschin, Jacob M Gluski, Eileen Nguyen, Hanna Silberberg, James H Thompson, Alexander T Chesler, Claire E Le Pichon

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 64 citations in OpenAlex.

  1. A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.Annals of clinical and translational neurology · 2022
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Maladaptive immunity to the microbiota promotes neuronal hyperinnervation and itch via IL-17A.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Josette J Wlaschin *Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.
Jacob M Gluski *Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.
Eileen Nguyen *National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, United States.
Hanna SilberbergEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.
James H ThompsonNational Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, United States.
Alexander T CheslerNational Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, United States.ORCID 0000-0002-3131-0728
Claire E Le PichonEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.ORCID 0000-0002-9274-3615
National Institutes of Health · US

Funding

The neuronal stress response in neurodegenerative disease and painZIAHD008966 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LE PICHON, CLAIRE · 2017 to 2025
$17.1M
Studies on the molecular, cells, and circuit that underlie somatosensation and painZIAAT000028 · NCCIH · NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH · PI CHESLER, ALEXANDER · 2014 to 2025
$12.0M
NCCIH NIH HHS Intramural Research ProgramNICHD NIH HHS Intramural Research ProgramNIH HHS Intramural Research Program - DDIR Innovation Award
6 · The paper itself

Abstract

Neuropathic pain resulting from nerve injury can become persistent and difficult to treat but the molecular signaling responsible for its development remains poorly described. Here, we identify the neuronal stress sensor dual leucine zipper kinase (DLK;

Indexed as

AnimalsDisease Models, AnimalFemaleGene Expression RegulationGliosisHyperalgesiaMacrophage Colony-Stimulating FactorMaleMAP Kinase Kinase KinasesMiceMice, TransgenicMicrogliaNerve Tissue ProteinsNeuralgiaPeripheral Nerve InjuriesSciatic NerveMacrophage Colony-Stimulating FactorMAP Kinase Kinase Kinasesmitogen-activated protein kinase kinase kinase 12Nerve Tissue Proteinskinasemechanical allodyniamicrogliamouseneuropathicneurosciencepainsomatosensation

Identifiers

PMID29968565
PMCPMC6029846
OpenAlexW2811262517

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.